Pregled bibliografske jedinice broj: 449021
Lipoprotein(a) predicts progression of carotid artery intima-media thickning in patients with type 2 diabetes : A four-year follow-up
Lipoprotein(a) predicts progression of carotid artery intima-media thickning in patients with type 2 diabetes : A four-year follow-up // Wiener klinische Wochenschrift, 122 (2010), 5/6; 159-164 doi:10.1007/s00508-010-1318-0 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 449021 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Lipoprotein(a) predicts progression of carotid artery intima-media thickning in patients with type 2 diabetes : A four-year follow-up
Autori
Boras, Jozo ; Ljubić, Spomenka ; Car, Nikica ; Metelko, Željko ; Petrovečki, Mlade ; Vučić Lovrenčić, Marijana ; Reiner, Željko
Izvornik
Wiener klinische Wochenschrift (0043-5325) 122
(2010), 5/6;
159-164
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
lipoprotein(a); intima-media thickness; diabetes mellitus; carotid artery plaques; cardiovascular risk
Sažetak
The aim was to establish whether increased serum lipoprotein (a) (Lp(a)) significantly contributed to an increase in intima-media thickness (IMT) and the number of carotid artery plaques, and consequently cardiovascular risk in patients with type 2 diabetes mellitus. The levels of Lp(a), IMT and the number of carotid artery plaques were determined at the beginning of the study in 146 type 2 diabetic patients. IMT and the number of plaques were again determined after four years of follow-up. Subjects were divided into two groups according to serum Lp(a) levels (> or 30 mg/dL). IMT was assessed by high-resolution B-mode ultrasound. The studied groups revealed no significant differences in baseline IMT (p=0.112) according to Lp(a) level. After follow-up IMT was significantly greater in patients with higher Lp(a) level than in those with lower Lp(a) level (1.24 + 0.22 mm vs. 1.15+0.17 mm, respectively ; p=0.05). Mean increase in IMT over four years was 0.12 mm (0.030 mm/yr.) in the group with low Lp(a) level and 0.17 mm (0.043 mm/yr.) in the group with high Lp(a) level. Multivariate analysis indicated that IMT value depended on Lp(a), and not on triglyceride and HDL-cholesterol levels. No significant difference in baseline and follow-up number of plaques was observed between the groups (p=0.276 vs p=0.355, respectively). These results point to Lp(a) as an independent, genetically determined risk factor associated with IMT progression in type 2 diabetes.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
045-0450961-0958 - Uloga adiponektina i upalnih čimbenika u razvoju komplikacija šećerne bolesti (Ljubić, Spomenka, MZOS ) ( CroRIS)
108-1080134-0121 - Percepcija i prevencija čimbenika rizika za aterosklerozu u Hrvatskoj (Reiner, Željko, MZOS ) ( CroRIS)
Ustanove:
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac,
Medicinski fakultet, Zagreb
Profili:
Željko Reiner
(autor)
Nikica Car
(autor)
Željko Metelko
(autor)
Spomenka Ljubić
(autor)
Marijana Vučić Lovrenčić
(autor)
Jozo Boras
(autor)
Poveznice na cjeloviti tekst rada:
Pristup cjelovitom tekstu rada doi springerlink.metapress.com www.springerlink.comCitiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE